SCHEMBL8715949

SCHEMBL8715949

O=C1CSC2=NC=CNN12

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16291646 0.60
SCHEMBL12793527 0.53 NPSR1 (0.34) NPSR1
SCHEMBL3490997 0.52 NPSR1 (0.36) NPSR1
SCHEMBL8956616 0.47
SCHEMBL1692574 0.45
SCHEMBL4073488 0.45
SCHEMBL14409703 0.45
SCHEMBL3294957 0.45
SCHEMBL686422 0.45
SCHEMBL11338059 0.44

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0880363-A1 COMBINATIONS, HAVING IMMUNOSUPPRESSIVE EFFECTS, CONTAINING A CYCLOOXYGENASE-2 INHIBITOR AND A LEUKOTRIENE A 4? HYDROLASE INHIBITOR G.D. SEARLE & CO. (US) 1998-12-02 EP disclosed
WO-1997029774-A1 COMBINATIONS, HAVING IMMUNOSUPPRESSIVE EFFECTS, CONTAINING A CYCLOOXYGENASE-2 INHIBITOR AND A LEUKOTRIENE A4 HYDROLASE INHIBITOR G.D. SEARLE & CO. (US) 1997-08-21 WO disclosed
EP-0276805-B1 Substituted 3-phenyl-7H-thiazolo[3,2-b][1,2,4]triazin-7-ones, processes for their preparation, medicaments containing them and their use as well as some of the intermediates obtained during the preparation of said compounds HOECHST AKTIENGESELLSCHAFT (DE) 1993-03-17 EP disclosed
US-4908364-A Pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1990-03-13 US disclosed
EP-0276805-A2 Substituted 3-phenyl-7H-thiazolo[3,2-b][1,2,4]triazin-7-ones, processes for their preparation, medicaments containing them and their use as well as some of the intermediates obtained during the preparation of said compounds HOECHST AKTIENGESELLSCHAFT (DE) 1988-08-03 EP disclosed